Navigation Links
MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
Date:11/17/2011

DALLAS, November 17, 2011 /PRNewswire/ --

The report "Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast) [http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html]", as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America (U.S. & Canada), Europe (Germany, France, U.K., Italy, and Spain) and emerging markets (Brazil, India, China, Russia, Turkey, and South Korea).

Browse market data tables and in-depth TOC on Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast).
http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html
Early buyers will receive 10% customization on reports.

The prostate is an exocrine gland found in men, located in the groin area just below the bladder and in front of the rectum. In prostate cancer, cells within the gland mutate into cancer cells. Further, these affected cells start killing the other healthy gland cells, and can spread to the other body parts. Prostate cancer is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancerous death in men. Globally, about 899,000 men were diagnosed with prostate cancer in 2008 and it is estimated that this number will get doubled (1.7 million) by 2030.

Global prostate cancer therapeutics market [ http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html ] was valued at $2,713 million in 2010 and it is expected to reach $6,457 million, by 2020. It is estimated that the market will grow at a CAGR of 11.4% and 6.8% from 2010 to 2015 and 2015 to 2020 respectively. By therapy, hormonal therapy is dominating the global prostate cancer drugs market with 66% market share in 2010 and expected to account for 53% market share in 2020. However, by 2020, immunotherapy and targeted therapy will significantly gain market share due to advantages such as increase in the overall survival and progression free survival with benign side effects profile.

In 2010, Europe dominated the global prostate cancer drug market by accounting to 43% market share; followed by Europe is North America with the share of 42%.

The major players in the market as of 2010 include AstraZeneca PLC (U.K.), Sanofi-Aventis (France), Ipsen (France), Tolmar Inc (U.S.), Abbott (U.S.), Astellas Pharma Inc (Japan), Indevus Pharmaceuticals Inc (U.S.), Dendreon Corporation (U.S.), and Ferring Pharmaceuticals (Switzerland).

Other Reports by MarketsandMarkets


Upcoming Market Research by MarketsandMarkets


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical, pharmaceuticals [ http://www.marketsandmarkets.com/pharmaceutical-market-research-3.html ], semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com.

Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/
http://twitter.com/marketsmarkets



'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
2. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
3. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
4. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
5. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
6. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
7. MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015
8. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
9. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
10. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
11. Forward step in forecasting global warming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Information Management Services ( IMS ) is pleased to announce a major upgrade ... and is so significant it was endowed with a new name, BSI Engage. ... a streamlined layout and a more intuitive format for navigating the system. ...
(Date:2/8/2016)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has gone live. On Thursday, ... mobile-friendly. Visit the new site: www.diplomat.is ... ... ... "The goal was to reimagine the website and create ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... 4, 2016 - New FDA action date of ... New FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast ... decade indicated for the treatment of signs and symptoms of dry ... the potential to be the only product approved in the U.S. in the past decade ...
Breaking Biology Technology:
(Date:2/3/2016)... PUNE, India , February 3, 2016 ... to the new market research report "Automated Fingerprint Identification ... (Tenprint Search, Latent Search), Application (Banking & Finance, Government, ... 2020", published by MarketsandMarkets, the market is expected to ... estimated CAGR of 21.0% between 2015 and 2020. The ...
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
Breaking Biology News(10 mins):